1. Home
  2. LCNB vs VYGR Comparison

LCNB vs VYGR Comparison

Compare LCNB & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

HOLD

Current Price

$16.11

Market Cap

238.1M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.32

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCNB
VYGR
Founded
1877
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.1M
194.0M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
LCNB
VYGR
Price
$16.11
$4.32
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
20.2K
808.0K
Earning Date
04-30-2026
06-10-2026
Dividend Yield
5.43%
N/A
EPS Growth
68.04
N/A
EPS
1.63
N/A
Revenue
$6,445,000.00
$10,135,000.00
Revenue This Year
$8.50
N/A
Revenue Next Year
$3.66
$71.77
P/E Ratio
$9.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.34
$2.65
52 Week High
$17.89
$5.55

Technical Indicators

Market Signals
Indicator
LCNB
VYGR
Relative Strength Index (RSI) 33.73 54.31
Support Level $15.24 $3.83
Resistance Level $16.44 $4.43
Average True Range (ATR) 0.46 0.32
MACD -0.13 0.06
Stochastic Oscillator 9.01 39.72

Price Performance

Historical Comparison
LCNB
VYGR

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: